Sign in

CIK 0001699031

  • Non-accelerated filer
  • Emerging growth company

GRAIL, Inc.

Sign in to watch
Ticker
GRAL
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
863673636
Phone
+1 833-694-2553
Business address
250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
Former names
GRAIL, LLC
  1. 4 Grant or award Director acquired 1,828 shares (grant or award)
  2. 4 Open-market sale Chief Financial Officer sold 30,452 shares at $14.02 ($426,937)
  3. 4 Derivatives Options or other derivatives
  4. 4 Grant or award Director acquired 31,055 shares (grant or award)
  5. 4 Grant or award Director acquired 210 shares (grant or award)
  6. 4 Grant or award Director acquired 248 shares (grant or award)
  7. 4 Grant or award Director acquired 296 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award Director acquired 978 shares (grant or award)
  10. 4 Grant or award Director acquired 1,656 shares (grant or award)
  11. 4 Grant or award Director acquired 1,054 shares (grant or award)
  12. 4 Open-market sale Chief Executive Officer sold 123,454 shares at $14.02 ($1,730,825)
  13. 4 Open-market buy 10% owner bought 78,829 shares at an average $13.00 ($1,024,698)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Grant or award Chief Executive Officer acquired 260,080 shares (grant or award)
  16. 4 Grant or award President acquired 259,780 shares (grant or award)
  17. 4 Grant or award Chief Financial Officer acquired 125,300 shares (grant or award)
  18. 4 Open-market sale Chief Financial Officer sold 15,641 shares at $16.25 ($254,121)
  19. 4 Open-market sale President sold 74,084 shares at $16.25 ($1,203,650)
  20. 4 Grant or award Chief Executive Officer acquired 475,178 shares (grant or award)

Page 5 of 6 · 115 filings